Pharmaceutical composition for treating atherosclerosis and application thereof

Abstract

The invention belongs to a pharmaceutical composition for treating atherosclerosis and its application; the pharmaceutical composition is prepared from the following raw materials: cyclovir buxicine D, barretoxin, and swertiamarin; it has stable quality control, It is safe and effective, natural and non-toxic, and suitable for long-term use.

Description

technical field [0001] The invention belongs to the technical field of medicine, and in particular relates to a pharmaceutical composition for treating atherosclerosis and its application. Background technique [0002] Atherosclerosis is a kind of arteriosclerosis, which mainly occurs in the intima of large and medium arteries, and yellow atheromatous plaques containing cholesterol and fats appear, which are mostly caused by lipid metabolism disorders and neurovascular dysfunction. Often lead to thrombosis, blood supply disorders. The onset of atherosclerosis is more common in men over 40 years old and postmenopausal women. The disease is often accompanied by hypertension, hypercholesterolemia or diabetes. Atherosclerosis is a common disease, frequently-occurring disease, one of the diseases with high mortality and disability, which seriously endangers human life and health. It is common in mental workers and is also one of the main causes of death in the elderly. . [0...

AI Technical Summary

Problems solved by technology

General prevention is mainly based on reasonable diet, physical exercise, and attention to rest, but the effect is not ideal

Images